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SOME SIMILARITIES BETWEEN
IMMUNE RESPONSE DURING
PREGNANCY AND CHRONIC HELMINTH
INFECTIONS EXIST
Pregnancy is a unique immunological sta-
tus with different hormonal and immuno-
logical alterations. Pregnancy hormones
(including progesterone, glucocorticoids,
estradiol, and estriol) increase over the
course of pregnancy and significantly
modulate the immunological shift that
occurs over the three trimesters of preg-
nancy (1). In contrast, helminth infec-
tions are the most common infectious
diseases in developing countries. Soil-
transmitted helminths (ascariasis, trichuri-
asis, and hookworm), schistosomiasis, and
lymphatic filariasis are the most common
helminthiasis. Most helminth infections
have minor clinical symptoms; thus, the
infection is left untreated and may remain
chronic for multiple years (2).
It is well-documented that a woman’s
immune response during pregnancy and
chronic helminth infections shift toward
Type 2 immunity and anti-inflammatory
cytokines (1, 3–6). During pregnancy, the
activities of CD4+ T cells into helper T cell
type 2 (Th2) and their anti-inflammatory
cytokines [including interleukin-4 (IL-4),
IL-5, and IL-10] increase. Inversely, the
activities of T-helper 1 (Th1) cells and their
inflammatory cytokines [as well as inflam-
matory macrophages and natural killer
(NK) cells] decrease (1). These immuno-
logical shifts away from inflammatory
responses are necessary for a successful
pregnancy (1, 3). For example, activat-
ing cytotoxic cells (including NK or T
cells and inflammatory cytokines such as
IFN-γ and TNF-α) can damage the pla-
centa and fetus (3). Moreover, the elevation
of anti-inflammatory factors like IL-10 can
prevent spontaneous abortions in murine
models (7).
Similar to immune response during
pregnancy, the immune response dur-
ing a helminth infection shifts toward
Th2 and anti-inflammatory status. During
chronic helminth infections, the increased
activation and expansion of CD4+ Th2
cells (including eosinophils, mast cells,
basophils, and the antibody isotypes IgG1,
IgG4, and IgE) occur. Moreover, produc-
tion of the cytokines IL-4, IL-5, IL-9,
IL-10, IL-13, and IL-21 and transform-
ing growth factor-β (TGF-β) increases (4,
5). On the other hand, several studies in
murine models reveal that helminth infec-
tions manipulate host hormones for its
own benefit [reviewed in Ref. (8)]. In
the case of Taenia crassiceps infection (a
model for human cysticercosis), infected
female mice showed an increase estrogen
levels after 8 weeks post-infection. Infected
male also showed increase serum estra-
diol and decrease testosterone levels. These
hormonal changes lead to increase par-
asite density in both genders (9). Prog-
esterone treatment in mice with T. cras-
siceps infection increased parasite loads
and expression of the Th2 cytokine pro-
file (IL-4, IL-6, and IL-10) in both genders
(10). These findings reveal that female sex
hormones are favorable for T. crassiceps
infection and the infection is associated
with Type 2 immunity. Hormonal regu-
lation during helminth infections is often
associated with increased parasite survival
and Type 2 immunity [reviewed in Ref.
(11, 12)], which negatively affect immune
response to intracellular pathogens.
In contrast to immune response dur-
ing pregnancy and chronic helminth infec-
tions, the protective immune response
against the majority of the intracellular
pathogens are mediated by Th1 cells and
their cytokines (including IFN-γ, TNF-
α, and IL-1) (13). Furthermore, increased
activation and expansion of cytotoxic
CD8+ T cells, NK cells, neutrophils, and
macrophages occur during infection with
intracellular pathogens (4, 13).
Therefore, immune system during preg-
nancy or helminth infections gives a weaker
response to the infections that require
strong Th1 immune response. So, it is plau-
sible that a pregnant woman with chronic
helminth infections is more susceptible to
acquiring congenital infections due to syn-
ergic immunoregulatory effects of preg-
nancy and chronic helminth infections (see
the next sections).
INCREASE IN SUSCEPTIBILITY AND
SEVERITY TO INFECTIOUS DISEASES
DURING PREGNANCY
Immunological shifts toward Th2 response
during pregnancy increases a woman’s sus-
ceptibility and severity to several infec-
tious diseases such as malaria, measles,
influenza, and toxoplasmosis (1, 14, 15).
The results of a recent systematic review
revealed that pregnant women are more
susceptible to the acquisition of malaria,
HIV infection, and listeriosis. Also, preg-
nancy increased the severity of malaria,
influenza, hepatitis E, herpes simplex virus
(HSV), measles, and smallpox (14). Thus,
infectious diseases in pregnant women are
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more common and severe due to physio-
logical immunoregulation that require for
a successful pregnancy.
INCREASES IN SUSCEPTIBILITY AND
SEVERITY TO INFECTIOUS DISEASES
DURING CHRONIC HELMINTH
INFECTIONS
Activation of Th2 immune responses
and immunoregulatory pathways during
helminth infections potentially downreg-
ulates the effector functions that mediate
type 1 immune responses during intra-
cellular pathogens; therefore, both the
severity of and susceptibility to intra-
cellular pathogens are increasing (16).
Several studies support the finding that
helminth infections modulate immune
responses to HIV infection (16), Mycobac-
terium tuberculosis (16–18) and Plasmod-
ium species (16, 19, 20). Eradication
of helminth infections in HIV-positive
patients significantly inhibits the progres-
sion of HIV infection by attenuation of
the plasma viral load and increasing CD4
counts (21). The results of a random-
ized, double blind, placebo-controlled trial
demonstrated that treatment of Ascaris
lumbricoides infection in HIV-positive
patients significantly increased CD4+ T
cell counts and decreased viral load
compared with placebo (22). Moreover,
albendazole-treated patients had signifi-
cantly lower plasma IL-10 levels (23). A
study among Tanzanian women of repro-
ductive age showed that the prevalence of
HIV in women with urogenital schistoso-
miasis was threefold higher than women
without urogenital schistosomiasis (24).
Furthermore, it was observed that the den-
sities of CD4+ T cells and macrophages
in genital mucosa surrounding Schisto-
soma haematobium eggs were significantly
higher than in cervicovaginal mucosa with-
out ova (p= 0.034 and p= 0.018, respec-
tively) (25). In the subject of helminth–
tuberculosis co-infections, Elias et al. (26)
observed that individuals with helminth
infections had significantly lower levels
of IFN-γ production to M. tuberculosis
antigens compared with the albendazole-
treated group. Helminth co-infections also
impaired efficient host immune responses
to different bacterial pathogens (27–
32) as well as to Leishmania spp (33,
34) and Toxoplasma gondii (35). There-
fore, immunoregulation during chronic
helminth infections provides a suitable cir-
cumstance for acquisition of several infec-
tious diseases.
INCREASED RISK OF CONGENITAL
INFECTIONS IN PREGNANT WOMEN
WITH CHRONIC HELMINTH
INFECTIONS
As mentioned above, both pregnancy and
chronic helminth infections increase sus-
ceptibility and severity toward the intra-
cellular pathogens due to downregula-
tion of type 1 immune response. This
condition raises an important question:
do the pregnancy and chronic helminth
infections have synergic immunoregula-
tory effects? If this hypothesis is correct,
pregnant women with chronic helminth
infections may be more susceptible to con-
genital infections. However, there are some
studies conducted in this regard (Table S1
in Supplementary Material). As reported by
Gallagher et al. (36), helminth infections
increase the risk of mother-to-child trans-
mission of HIV infection. HIV-positive
pregnant mothers with chronic helminth
co-infection were found to have seven-
fold greater risk of HIV transmission to
their offspring (OR= 7.3, 95% CL 2.4–
33.7). Moreover, the increased risk of HIV
transmission was significantly associated
with higher production of IL-5/IL-13 by
cord blood lymphocytes (p< 0.001) (36).
The results from a randomized, placebo-
controlled trial among HIV-positive preg-
nant women in Uganda showed that hook-
worm and Trichuris infections were sig-
nificantly associated with increased HIV
viral load during pregnancy. Moreover,
when treated with albendazole, some
experienced reduced viral load within
6 weeks after treatment (37). The results
of a cross-sectional study in HIV-positive
pregnant women in Rwanda revealed
that the prevalence of soil-transmitted
helminths was 38%, malaria was 21%,
and malaria–helminth co-infection was
10%. Also, helminth infections were asso-
ciated with lower levels of hemoglobin
and CD4 counts in HIV-positive moth-
ers (38).
It has been proven the efficient vaccine
against intracellular infections requiring
cellular immunity and Th1 components
(39). There is also evidence that mater-
nal helminth infections suppress immune
response to postnatal immunization (40).
Elliott et al. (41) observed that maternal
hookworm infection was associated with
reduced maternal IFN-γ responses to crude
culture filtrate proteins (CFP) of M. tuber-
culosis. Interestingly, an increase IFN-γ, in
response to CFP, was found in mothers
who were treated with albendazole, but not
in untreated mothers. Conversely, lower
levels of IFN-γ, in response to CFP, was
observed in infants of hookworm-infected
mothers who were treated with albenda-
zole compared to those mothers receiving
a placebo (41). It was also observed that
the offspring of mothers infected with a
filarial worm (Mansonella perstans) had
higher levels of IL-10, in responses to CFP,
and tetanus toxoid (42). Webb et al. (43)
observed that albendazole therapy during
pregnancy was associated with lower lev-
els of IL-5 and IL-13 responses to tetanus
toxoid in infants of mothers with hook-
worm infection (see details in Table S1 in
Supplementary Material) (43).
Other studies were conducted in the
area of malaria–helminth co-infection dur-
ing pregnancy (20, 44–48). A recent meta-
analysis by Naing et al. (20) revealed that
pregnant women with hookworm infec-
tion had 1.36 times (OR: 1.36; 95% CI:
1.17–1.59) higher risk of malaria infec-
tion than those mothers without hook-
worm infection. Moreover, the risk of
malaria in primigravid mothers with soil-
transmitted helminth infections was 1.6
times (OR: 1.61; 95% CI: 1.3–1.99) higher
than multigravid mothers (20). The results
of a cross-sectional study among preg-
nant women in Ghana showed that moth-
ers with intestinal helminth infections
were at 4.8 times higher risk of acquiring
Plasmodium falciparum infection (47). A
study among pregnant women in Uganda
demonstrated that women with hookworm
and M. perstans infections had higher
risk of P. falciparum infection (44). The
odds ratio for P. falciparum infection
in mothers infected with hookworm was
1.53 (CI, 1.09–2.14), for mothers infected
with M. perstans 2.33 (CI, 1.47–3.69) and
for mothers infected with both hook-
worm and M. perstans 1.85 (CI, 1.24–
2.76) (44). Moreover, the study showed
that the offspring of mothers with hook-
worm and M. perstans infections dur-
ing pregnancy had significantly higher
rates of clinical malaria and asympto-
matic parasitemia in comparison with the
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children of uninfected mothers (45). It
was also observed that quarterly albenda-
zole therapy during childhood was asso-
ciated significantly with the reduced inci-
dence of clinical malaria (see details in
Table S1 in Supplementary Material) (46).
Henceforth, concurrent of helminth infec-
tions and pregnancy have serious conse-
quences on mothers and their offspring;
including increase susceptibility, severity,
and the risk of mother-to-child transmis-
sion of intracellular pathogens, as well as








It should be noted that most of the studies
described above are coming from develop-
ing countries with poor nutrition status.
Without adequate nutrition, immune sys-
tem fails to produce an effective response
to infections (49). On the other hand,
helminth infections are more prevalent
in developing countries with poor sanita-
tion. Conversely, helminth infections are
a cause of malnutrition and immune sys-
tem impairment (50). In this complex sit-
uation, pregnant women with helminth
infections may be more susceptible to
acquiring of congenital infections due to
the synergic immunoregulatory effects of
malnutrition, pregnancy, and helminth
infections.
As described above, pregnant women
with chronic helminth infections are more
susceptible to the acquisition and subse-
quent transmission of malaria (20, 44–48)
and HIV (36–38) infections to their off-
spring. It is also evident that helminth
infection associations during pregnancy
suppress immune responses to postnatal
immunization (40–43).
In conclusion, the synergic immunoreg-
ulatory effects of pregnancy and chronic
helminth infections offer a new insight into
the role of immune response to intracel-
lular pathogens. Therefore, increased sus-
ceptibility to several congenital infectious
diseases – and their severity – are plau-
sible. Hence, diagnosis and treatment of
helminth infections in pregnant women
should be given greater consideration.
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